| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |